Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


An Open Label, Two-way Crossover Study to Evaluate the PK Effects of Two Different Wafer Administration Protocols in Healthy Volunteers Under Fasted Conditions.


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT02857361

Organisation Name: iX Biopharma Ltd.

Overal Status: Completed

Start Date: July 2016

Last Update: August 19, 2016

Lead Sponsor: iX Biopharma Ltd.

Brief Summary: The study will look at whether it is preferable to administer two wafers simultaneously or separately.

Conditions:
  • Pain


Total execution time in seconds: 0.19888305664062